메뉴 건너뛰기




Volumn 30, Issue 21, 2012, Pages

Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; LOMUSTINE; TEMOZOLOMIDE;

EID: 84864033781     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.9565     Document Type: Article
Times cited : (48)

References (11)
  • 1
    • 43749094544 scopus 로고    scopus 로고
    • MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
    • Brandes AA, Franceschi E, Tosoni A, et al: MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192-2197, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2192-2197
    • Brandes, A.A.1    Franceschi, E.2    Tosoni, A.3
  • 2
    • 42649106522 scopus 로고    scopus 로고
    • Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
    • DOI 10.1016/S1470-2045(08)70125-6, PII S1470204508701256
    • Brandsma D, Stalpers L, Taal W, et al: Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461, 2008 (Pubitemid 351597795)
    • (2008) The Lancet Oncology , vol.9 , Issue.5 , pp. 453-461
    • Brandsma, D.1    Stalpers, L.2    Taal, W.3    Sminia, P.4    Van Den, B.M.J.5
  • 3
    • 84455185238 scopus 로고    scopus 로고
    • Pseudoprogression and pseudoresponse: Imaging challenges in the assessment of posttreatment glioma
    • Hygino da Cruz LC Jr, Rodriguez I, Domingues RC, et al: Pseudoprogression and pseudoresponse: Imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 32:1978-1985, 2011
    • (2011) AJNR Am J Neuroradiol , vol.32 , pp. 1978-1985
    • Hygino Da Cruz Jr., L.C.1    Rodriguez, I.2    Domingues, R.C.3
  • 4
    • 77951625266 scopus 로고    scopus 로고
    • Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group
    • Wen PY, Macdonald DR, Reardon DA, et al: Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol 28:1963-1972, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1963-1972
    • Wen, P.Y.1    Macdonald, D.R.2    Reardon, D.A.3
  • 7
    • 62449086667 scopus 로고    scopus 로고
    • Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide
    • Glas M, Happold C, Rieger J, et al: Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol 27:1257-1261, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 1257-1261
    • Glas, M.1    Happold, C.2    Rieger, J.3
  • 8
    • 24344436347 scopus 로고    scopus 로고
    • 18F]fluoroethyl)-l- tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas
    • discussion 505-511
    • 18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505-511; discussion 505-511, 2005
    • (2005) Neurosurgery , vol.57 , pp. 505-511
    • Rachinger, W.1    Goetz, C.2    Pöpperl, G.3
  • 9
    • 69549088562 scopus 로고    scopus 로고
    • Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: Clinical observations and working recommendations
    • Chaskis C, Neyns B, Michotte A, et al: Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: Clinical observations and working recommendations. Surg Neurol 72:423-428, 2009
    • (2009) Surg Neurol , vol.72 , pp. 423-428
    • Chaskis, C.1    Neyns, B.2    Michotte, A.3
  • 10
    • 33846955124 scopus 로고    scopus 로고
    • Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
    • Chamberlain MC, Glantz MJ, Chalmers L, et al: Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82:81-83, 2007
    • (2007) J Neurooncol , vol.82 , pp. 81-83
    • Chamberlain, M.C.1    Glantz, M.J.2    Chalmers, L.3
  • 11
    • 78650136376 scopus 로고    scopus 로고
    • Prolonged response without prolonged chemotherapy: A lesson from PCV chemotherapy in low-grade gliomas
    • Peyre M, Cartalat-Carel S, Meyronet D, et al: Prolonged response without prolonged chemotherapy: A lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol 12:1078-1082, 2010
    • (2010) Neuro Oncol , vol.12 , pp. 1078-1082
    • Peyre, M.1    Cartalat-Carel, S.2    Meyronet, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.